The Effectiveness of a Liver Disease Education Class for Providing Information to Patients and Their Families

por Kadokawa, Yukio, Katayama, Kazuhiro, Takahashi, Kozo, Fukushima, Nobuhisa, Tanaka, Setsu, Taniguchi, Yuko, Nawa, Takatoshi, Sakakibara, Mitsuru, Ohkawa, Kazuyoshi
Publicado 2017

Chemotherapy-Induced Sclerosing Cholangitis Caused by Systemic Chemotherapy

por Kusakabe, Akira, Ohkawa, Kazuyoshi, Fukutake, Nobuyasu, Sakakibara, Mitsuru, Imai, Toshihiro, Abe, Yutaro, Takada, Ryoji, Ikezawa, Kenji, Nawa, Takatoshi, Ashida, Reiko, Kimura, Toshihiro, Nagata, Shigenori, Katayama, Kazuhiro
Publicado 2019

Prognostic Factors for Patients With a Large Number of Hepatocellular Carcinoma Nodules

por Abe, Yutaro, Ohkawa, Kazuyoshi, Sakakibara, Mitsuru, Nawa, Takatoshi, Fukutake, Nobuyasu, Ikezawa, Kenji, Takada, Ryoji, Kusakabe, Akira, Imai, Toshihiro, Nakanishi, Katsuyuki, Tabuchi, Takahiro, Hikita, Hayato, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo, Katayama, Kazuhiro
Publicado 2020

Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis

por Shirai, Kumiko, Hikita, Hayato, Sakamori, Ryotaro, Doi, Akira, Tahata, Yuki, Sakane, Sadatsugu, Kamada, Yoshihiro, Murai, Kazuhiro, Nishio, Akira, Yamada, Ryoko, Kodama, Takahiro, Nozaki, Yasutoshi, Kakita, Naruyasu, Ishida, Hisashi, Nakanishi, Fumihiko, Morishita, Naoki, Imanaka, Kazuho, Sakakibara, Mitsuru, Tatsumi, Tomohide, Miyoshi, Eiji, Takehara, Tetsuo
Publicado 2022

Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral

por Matsumae, Takayuki, Kodama, Takahiro, Tahata, Yuki, Myojin, Yuta, Doi, Akira, Nishio, Akira, Yamada, Ryoko, Nozaki, Yasutoshi, Oshita, Masahide, Hiramatsu, Naoki, Morishita, Naoki, Ohkawa, Kazuyoshi, Hijioka, Taizo, Sakakibara, Mitsuru, Doi, Yoshinori, Kakita, Naruyasu, Yakushijin, Takayuki, Sakamori, Ryotaro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2023

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

por Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Doi, Akira, Tahata, Yuki, Ohkawa, Kazuyoshi, Oshita, Masahide, Miyazaki, Masanori, Yakushijin, Takayuki, Nozaki, Yasutoshi, Matsumoto, Kengo, Tanaka, Satoshi, Kaneko, Akira, Iio, Sadaharu, Nawa, Takatoshi, Yamada, Yukinori, Morishita, Naoki, Usui, Takeo, Hiramatsu, Naoki, Doi, Yoshinori, Sakakibara, Mitsuru, Imanaka, Kazuho, Yoshida, Yuichi, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2023